Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761832
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRENT-ICU Study)Hospital H+ QueretaroCompleted
NCT07761832Completed
—
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRE...Hospital H+ Queretaro
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
NCT07761078
Jingwanhong for BedsoresFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet Recruiting
NCT07759206
Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade MonitoringUniversity of MinnesotaCompletedNot Applicable
NCT07759206Completed
Not Applicable
Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade MonitoringUniversity of Minnesota
NCT07760675
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE.Canadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07760675Not Yet Recruiting
Not Applicable
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Ca...Canadian Institutes of He...
NCT07760285
Virtual Reality Versus Intradialytic Neuromuscular Electrical Stimulation on Renin Hormone in Chronic Kidney PatientsAdly A AdamCompletedNot Applicable
NCT07760285Completed
Not Applicable
Virtual Reality Versus Intradialytic Neuromuscular Electrical Stimulation on Ren...Adly A Adam
NCT07761026
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures the Real-world Experiences of People Living With Autoimmune Neurology Conditions. Launching in Myasthenia Gravis (MG), we Plan to Evaluate Expansion to Other Conditions Across Autoimmune Neurology.Alira HealthRecruiting
NCT07761026Recruiting
—
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures th...Alira Health
NCT07760831
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisJiangsu HengRui Medicine Co., Ltd.Not Yet RecruitingPhase 1
NCT07760831Not Yet Recruiting
Phase 1
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerativ...Jiangsu HengRui Medicine...
NCT07761416
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer PreventionSt. Joseph's Healthcare HamiltonNot Yet RecruitingEarly Phase 1
NCT07761416Not Yet Recruiting
Early Phase 1
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer Preventi...St. Joseph's Healthcare H...
NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes AssociationNot Yet RecruitingPhase 2
NCT07760948Not Yet Recruiting
Phase 2
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes Associa...
NCT07759180
Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior BlepharitisAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaCompletedNot Applicable
NCT07759180Completed
Not Applicable
Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior BlepharitisAzienda Ospedaliera OO.RR...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759128
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety DisorderOtsuka Pharmaceutical Development & Commercialization, Inc.RecruitingPhase 3
NCT07759128Recruiting
Phase 3
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With G...Otsuka Pharmaceutical Dev...
NCT07759830
A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Menopausal Hot Flushes and Night Sweats.Queen's University, BelfastCompletedNot Applicable
NCT07759830Completed
Not Applicable
A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Meno...Queen's University, Belfa...
NCT07760064
This Study Will be Directed Toward Evaluating Peri-implant Tissue Behavior, Pink Esthetic Score, Patient Satisfaction and Marginal Accuracy Associated With Biologically Oriented Preparation Technique for Implant Supported Crowns.Kholoud Mohamed Mahmoud SolimanCompletedNot Applicable
NCT07760064Completed
Not Applicable
This Study Will be Directed Toward Evaluating Peri-implant Tissue Behavior, Pink...Kholoud Mohamed Mahmoud S...
NCT07760961
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric HypoglycemiaVogenx, Inc.Not Yet RecruitingPhase 2
NCT07760961Not Yet Recruiting
Phase 2
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglyc...Vogenx, Inc.
NCT07761845
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn InjuriesAin Shams UniversityRecruiting
NCT07761845Recruiting
—
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of...Ain Shams University
NCT07759778
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu YiNot Yet RecruitingPhase 4
NCT07759778Not Yet Recruiting
Phase 4
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu Yi
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07761923
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07761923Not Yet Recruiting
Not Applicable
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska Institutet
Result Breakdown
Not yet recruiting11 (55%)
Completed6 (30%)
Recruiting3 (15%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 11 (5%)
Early Phase 11 (5%)
Phase 31 (5%)
Phase 41 (5%)